Belgian molecular Dx company obtains $7.3 million

02/15/2013 | GenomeWeb Daily News (free registration)

A funding round has pulled in $7.3 million for Multiplicom, a Belgian firm that develops research-use-only test kits for muscle disease, cystic fibrosis, kidney disease, heart failure and bowel cancer. The company will use the money to further develop its molecular diagnostic tests and expand its sales channels in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations